Johnson & Johnson Share Holder Equity 2010-2024 | JNJ

Johnson & Johnson share holder equity for the quarter ending June 30, 2024 was $71.538B, a 6.37% decline year-over-year.

  • Johnson & Johnson share holder equity for 2023 was $68.774B, a 10.46% decline from 2022.
  • Johnson & Johnson share holder equity for 2022 was $76.804B, a 3.76% increase from 2021.
  • Johnson & Johnson share holder equity for 2021 was $74.023B, a 16.98% increase from 2020.

Johnson & Johnson Share Holder Equity 2010-2024 | JNJ

  • Johnson & Johnson share holder equity for 2023 was $68.774B, a 10.46% decline from 2022.
  • Johnson & Johnson share holder equity for 2022 was $76.804B, a 3.76% increase from 2021.
  • Johnson & Johnson share holder equity for 2021 was $74.023B, a 16.98% increase from 2020.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$495.1B
Novo Nordisk (NVO)$424.5B
Merck (MRK)$270B
AbbVie (ABBV)$264.1B
AstraZeneca (AZN)$218.5B
Novartis AG (NVS)$218.4B
Pfizer (PFE)$201.2B
Sanofi (SNY)$133B
Innoviva (INVA)$953M